Consensus Santhera Pharmaceuticals Holding AG

Equities

SANN

CH1276028821

Real-time Estimate Cboe Europe Other stock markets 05:41:46 2024-06-13 am EDT			5-day change	1st Jan Change
10.02 ^CHF	+0.65%		+5.32%	+0.92%

Apr. 25	Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024
Apr. 25	Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows	MT

Evolution of the average Target Price on Santhera Pharmaceuticals Holding AG

Price target over the last 5 years

History of analyst recommendation changes

a490f241a98b53efd62134caf.2FA1nbUwrvkAzL6IARbAE5jUi2Vt9w351ePajZBMZ4Q.oCJS2OZexKhVo5OwM2emeNzmulMpvVeY5aaj6L0bBamAfX7E7GKWy0i8zQ~e7392adb3e0ffef052c350cd4408f556

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

9.95 CHF

Average target price

34.5 CHF

Spread / Average Target

+246.73%

High Price Target

39 CHF

Spread / Highest target

+291.96%

Low Price Target

30 CHF

Spread / Lowest Target

+201.51%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar